Literature DB >> 18024803

Behçet's disease: global epidemiology of an Old Silk Road disease.

Hiroshi Keino, Annabelle A Okada.   

Abstract

Mesh：

Year:  2007        PMID： 18024803      PMCID： PMC2095534          DOI： 10.1136/bjo.2007.124875

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  15 in total

Review 1.  Behçet disease.

Authors:  Paul A Yates; Joseph B Michelson
Journal:  Int Ophthalmol Clin       Date:  2006

Review 2.  Behçet's disease: general concepts and recent advances.

Authors:  Annabelle A Okada
Journal:  Curr Opin Ophthalmol       Date:  2006-12       Impact factor: 3.761

3.  A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

Authors:  Eric B Suhler; Justine R Smith; Michael S Wertheim; Andreas K Lauer; Daryl E Kurz; Terri D Pickard; James T Rosenbaum
Journal:  Arch Ophthalmol       Date:  2005-07

4.  Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.

Authors:  Ilknur Tugal-Tutkun; Abdulbaki Mudun; Meri Urgancioglu; Sevil Kamali; Esen Kasapoglu; Murat Inanc; Ahmet Gül
Journal:  Arthritis Rheum       Date:  2005-08

5.  Comparison of patients with Behçet's disease in the 1980s and 1990s.

Authors:  Atsushi Yoshida; Hidetoshi Kawashima; Yuta Motoyama; Hirobumi Shibui; Toshikatsu Kaburaki; Kazuyuki Shimizu; Kazuhiko Ando; Kiyono Hijikata; Yasuho Izawa; Kiyofumi Hayashi; Jiro Numaga; Yujiro Fujino; Kanjiro Masuda; Makoto Araie
Journal:  Ophthalmology       Date:  2004-04       Impact factor: 12.079

6.  Ocular features of Behcet's disease: an international collaborative study.

Authors:  Nobuyoshi Kitaichi; Akiko Miyazaki; Daiju Iwata; Shigeaki Ohno; Miles R Stanford; Hormoz Chams
Journal:  Br J Ophthalmol       Date:  2007-12       Impact factor: 4.638

7.  Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis.

Authors:  Shigeaki Ohno; Satoshi Nakamura; Sadao Hori; Machiko Shimakawa; Hidetoshi Kawashima; Manabu Mochizuki; Sunao Sugita; Satoki Ueno; Kazuyuki Yoshizaki; Goro Inaba
Journal:  J Rheumatol       Date:  2004-07       Impact factor: 4.666

8.  The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center.

Authors:  Emire Kural-Seyahi; Izzet Fresko; Nurhan Seyahi; Yilmaz Ozyazgan; Cem Mat; Vedat Hamuryudan; Sebahattin Yurdakul; Hasan Yazici
Journal:  Medicine (Baltimore)       Date:  2003-01       Impact factor: 1.889

Review 9.  Infliximab treatment of rheumatoid arthritis and Crohn's disease.

Authors:  Ibrahim K Nahar; Kam Shojania; Carlo A Marra; Abul H Alamgir; Aslam H Anis
Journal:  Ann Pharmacother       Date:  2003-09       Impact factor: 3.154

Review 10.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258
View more
  21 in total

1.  TNFAIP3 gene polymorphisms confer risk for Behcet's disease in a Chinese Han population.

Authors:  Hong Li; Qing Liu; Shengping Hou; Liping Du; Qingyun Zhou; Yan Zhou; Aize Kijlstra; Zheng Li; Peizeng Yang
Journal:  Hum Genet       Date:  2012-11-18       Impact factor: 4.132

2.  MicroRNA-146a expression and microRNA-146a rs2910164 polymorphism in Behcet's disease patients.

Authors:  W Ibrahim; B R Sakr; E Obaya; H Ghonem
Journal:  Clin Rheumatol       Date:  2018-07-10       Impact factor: 2.980

3.  Lessons of the month 2: A case of Behçet's disease: 70% have ophthalmic involvement.

Authors:  Ishna Auluck; Ayesha Karimi; Simon Taylor
Journal:  Clin Med (Lond)       Date:  2019-11       Impact factor: 2.659

4.  Behçet's Uveitis.

Authors:  Ilknur Tugal-Tutkun
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

5.  Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity.

Authors:  R Oktay Kaçmaz; John H Kempen; Craig Newcomb; Sapna Gangaputra; Ebenezer Daniel; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; Douglas A Jabs; C Stephen Foster
Journal:  Am J Ophthalmol       Date:  2008-08-16       Impact factor: 5.258

6.  Lower CYP2C9 activity in Turkish patients with Behçet's disease compared to healthy subjects: a down-regulation due to inflammation?

Authors:  Mustafa Tugrul Goktaş; Fazleen Hatta; Ozgur Karaca; Said Kalkisim; Levent Kilic; Ali Akdogan; Melih O Babaoglu; Atilla Bozkurt; Anders Helldén; Leif Bertilsson; Umit Yasar
Journal:  Eur J Clin Pharmacol       Date:  2015-08-02       Impact factor: 2.953

7.  Lack of an association of PD-1 and its ligand genes with Behcet's disease in a Chinese Han population.

Authors:  Qianli Meng; Haike Guo; Shengping Hou; Zhengxuan Jiang; Aize Kijlstra; Peizeng Yang
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

8.  No association of PTPN22 polymorphisms with susceptibility to ocular Behcet's disease in two Chinese Han populations.

Authors:  Qi Zhang; Shengping Hou; Zhengxuan Jiang; Liping Du; Fuzhen Li; Xiang Xiao; Aize Kijlstra; Peizeng Yang
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

9.  Association between polymorphisms of FCRL3, a non-HLA gene, and Behçet's disease in a Chinese population with ophthalmic manifestations.

Authors:  Ke Li; Min Zhao; Shengping Hou; Liping Du; Aize Kijlstra; Peizeng Yang
Journal:  Mol Vis       Date:  2008-11-28       Impact factor: 2.367

10.  Lack of association of two polymorphisms of IRF5 with Behcet's disease.

Authors:  Haijun Li; Peizeng Yang; Zhengxuan Jiang; Shengping Hou; Lin Xie
Journal:  Mol Vis       Date:  2009-10-07       Impact factor: 2.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.